GALLINORO, EMANUELE
 Distribuzione geografica
Continente #
EU - Europa 87
NA - Nord America 81
AS - Asia 22
Totale 190
Nazione #
US - Stati Uniti d'America 79
IE - Irlanda 40
IT - Italia 25
SG - Singapore 15
GB - Regno Unito 8
DE - Germania 5
CN - Cina 3
CA - Canada 2
CZ - Repubblica Ceca 2
TW - Taiwan 2
AT - Austria 1
CH - Svizzera 1
DK - Danimarca 1
FI - Finlandia 1
FR - Francia 1
IN - India 1
LU - Lussemburgo 1
NL - Olanda 1
TR - Turchia 1
Totale 190
Città #
Dublin 37
Santa Clara 27
Chandler 17
Singapore 12
Naples 9
New York 8
Ercolano 5
Frankfurt am Main 3
Bremen 2
Camden 2
Chiayi County 2
Chongqing 2
London 2
Milan 2
Seattle 2
Toronto 2
Amsterdam 1
Andover 1
Ashburn 1
Beijing 1
Boardman 1
Bologna 1
Brdo 1
Brno 1
Cambridge 1
Casavatore 1
Edinburgh 1
Fairfield 1
Helsinki 1
Istanbul 1
Juelsminde 1
Laurel 1
Luxembourg 1
Manchester 1
Paris 1
Princeton 1
Pune 1
Rome 1
Roxbury 1
Vienna 1
Zurich 1
Totale 159
Nome #
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 46
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 42
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy 36
In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study 26
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes 19
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 13
Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy 13
Myocardial sodium–glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 5
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 2
Totale 202
Categoria #
all - tutte 1.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 0 0 11 3
2022/202365 1 0 2 7 7 6 0 6 29 1 6 0
2023/202453 2 5 1 2 11 11 2 5 2 2 6 4
2024/202570 2 0 1 10 21 36 0 0 0 0 0 0
Totale 202